Aldeyra Therapeutics, Inc. (ALDX)
1.695
-0.08
(-4.78%)
USD |
NASDAQ |
May 27, 16:00
1.695
0.00 (0.00%)
After-Hours: 18:43
Aldeyra Therapeutics Cash from Investing (Quarterly) : 0.00 for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| AbbVie, Inc. | -574.00M |
| Rhythm Pharmaceuticals, Inc. | 57.05M |
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| ADMA Biologics, Inc. | 2.404M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -5.110M |
| Cash from Financing (Quarterly) | 0.0711M |
| Free Cash Flow | -25.99M |
| Free Cash Flow Per Share (Quarterly) | -0.0847 |
| Free Cash Flow to Equity (Quarterly) | -5.093M |
| Free Cash Flow to Firm (Quarterly) | -4.641M |
| Free Cash Flow Yield | -25.48% |